| Title |
Author |
Type |
Date |
Words |
| Win PS250 of Dermatique skincare range; Competition. |
|
|
May 9, 2013 |
228 |
| People with psoriasis suffer social stigma. |
|
|
Apr 18, 2013 |
383 |
| EpiCast Report: Psoriasis - Epidemiology Forecast to 2022. |
|
Report |
Apr 16, 2013 |
1049 |
| Ask Danielle. |
|
|
Apr 15, 2013 |
119 |
| Ask Danielle. |
|
|
Apr 15, 2013 |
117 |
| Ask Danielle. |
|
|
Apr 15, 2013 |
119 |
| Belgium,Netherlands : arGEN-X announces preclinical development of ARGX-112 for dermatology. |
|
|
Mar 25, 2013 |
415 |
| Israel : PSORIASIS drug introduced by Ben-Gurion U. researchers and Teva Pharmaceutical Industries. |
|
|
Mar 21, 2013 |
341 |
| LEO Pharma Puts Patients at the Heart of Innovation. |
|
|
Mar 19, 2013 |
825 |
| LEO Pharma Puts Patients at the Heart of Innovation. |
|
|
Mar 19, 2013 |
832 |
| TWEETS & POSTS. |
|
|
Mar 19, 2013 |
556 |
| Virobay and LEO Pharma Initiate a Phase 1 Trial of VBY-891, a Compound Intended for Oral Treatment of Psoriasis. |
|
|
Mar 18, 2013 |
892 |
| Virobay and LEO Pharma Initiate a Phase 1 Trial of VBY-891, a Compound Intended for Oral Treatment of Psoriasis. |
|
|
Mar 18, 2013 |
902 |
| Provision of Immunosuppressive agents. |
|
|
Mar 12, 2013 |
123 |
| Pills made from red grapes skin could help us live to 150. |
|
|
Mar 11, 2013 |
291 |
| Celebrity clinic; Vital health Kim Kardashian. |
|
|
Mar 6, 2013 |
291 |
| The International Federation of Psoriasis Associations gathered experts to discuss the global health issue of psoriasis. |
|
|
Mar 6, 2013 |
680 |
| Botulinum toxin may hold key for treatment of common skin diseases. |
|
Disease/Disorder overview |
Mar 4, 2013 |
352 |
| Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model. |
|
|
Mar 2, 2013 |
1137 |
| Research and Markets: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2012. |
|
|
Mar 1, 2013 |
408 |
| Watch for postpartum exacerbation of psoriasis. |
Jancin, Bruce |
|
Mar 1, 2013 |
835 |
| New Research Report on Dermatology Therapeutics Market to 2018 by MarketResearchReports. |
|
|
Feb 27, 2013 |
645 |
| Antares Pharma Announces FDA Acceptance of New Drug Application for OTREXUP[TM]. |
|
|
Feb 27, 2013 |
808 |
| Denmark : LEO Pharma and 4SC Discovery announce exclusive research and license agreement. |
|
|
Feb 27, 2013 |
434 |
| LEO Pharma and 4SC Discovery Announce Exclusive Research and License Agreement. |
|
|
Feb 26, 2013 |
833 |
| LEO Pharma and 4SC Discovery Announce Exclusive Research and License Agreement. |
|
|
Feb 26, 2013 |
844 |
| PsorCARE Program by LEO Pharma Asia Focuses on Treatment Adherence to Improve Psoriasis Treatment Outcomes. |
|
|
Jan 27, 2013 |
1984 |
| Kim Kardashian yelps as Kourtney squirts breast milk onto her leg to heal psoriasis. |
|
|
Jan 26, 2013 |
283 |
| Keep your psoriasis at bay in the winter. |
|
|
Jan 24, 2013 |
399 |
| Keep your psoriasis at bay in the winter. |
|
|
Jan 24, 2013 |
443 |
| Research and Markets: Chronic Plaque Psoriasis - Pipeline Review, H2 2012. |
|
|
Jan 24, 2013 |
377 |
| Leading Dermatologist Michael P. Heffernan, M.D. and Renowned Rheumatologist Alisa E. Koch, M.D. Join Lilly Autoimmune Team. |
|
|
Jan 3, 2013 |
1285 |
| Research and Markets: Severe Psoriasis - Pipeline Review, H2 2012. |
|
|
Jan 2, 2013 |
394 |
| Antares Pharma Announces Submission of New Drug Application for OTREXUP[TM]. |
|
|
Dec 17, 2012 |
1377 |
| International Federation of Psoriasis Associations: Psoriasis - putting a global health challenge in the spotlight. |
|
|
Dec 12, 2012 |
918 |
| SJW and psoriasis. |
|
|
Dec 1, 2012 |
552 |
| PhotoMedex Supports Psoriasis and Vitiligo Patients Through New "Live Clear. Live Free." Campaign. |
|
|
Nov 29, 2012 |
921 |
| Surveyed Dermatologists Estimate that Half of Psoriasis Patients Who are Treated with Janssen Biotech/Janssen-Cilag's Stelara Have Previously Failed Treatment with at Least One TNF-Alpha Inhibitor. |
|
|
Nov 29, 2012 |
546 |
| Psoriasis drugs may help 'slow dementia'. |
|
|
Nov 26, 2012 |
390 |
| Research and Markets: Chronic Plaque Psoriasis Global Clinical Trials Review, H2, 2012. |
|
|
Nov 21, 2012 |
320 |
| Indirect comparison trial favors adalimumab for psoriasis. |
Jancin, Bruce |
Clinical report |
Nov 15, 2012 |
567 |
| Research and Markets: Global Psoriasis Epidemiology and Patient Flow Analysis - 2012. |
|
Clinical report |
Nov 6, 2012 |
284 |
| Psoriasis flares rapidly post partum, expert explains. |
Mechcatie, Elizabeth |
Medical condition overview |
Nov 1, 2012 |
926 |
| Idera Pharmaceuticals Present New Data That Show Toll-like Receptor Antagonists Inhibit Inflammasome Activation and Suppress Induction of Interleukin 1 Beta in Autoimmune Disease Models. |
|
|
Oct 30, 2012 |
1211 |
| ACTION APPEAL ON WORLD PSORIASIS DAY. |
|
|
Oct 29, 2012 |
372 |
| International Federation of Psoriasis Associations: Put Psoriasis on the Agenda Now! |
|
Disease/Disorder overview |
Oct 29, 2012 |
529 |
| UK Survey Calls for Further Education to Help Eliminate Common Misconceptions About Psoriasis. |
|
|
Oct 29, 2012 |
1221 |
| Lake Consumer Products Announces Innovative New MG217 Psoriasis Treatment Cream that's Unlike Anything Else on the Market. |
|
|
Oct 29, 2012 |
479 |
| LEO Pharma Inc. Receives FDA Approval for Taclonex[R] (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064% for Body Plaque Psoriasis. |
|
|
Oct 26, 2012 |
1126 |
| Research and Markets: Dermatology Therapeutics Market to 2018 - Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment. |
|
|
Oct 26, 2012 |
460 |
| Research and Markets: U.S. Physician and Payer Perspectives on Emerging Immunomodulators in Psoriasis. |
|
|
Oct 24, 2012 |
292 |
| Dermatology Therapeutics Market to 2018 - Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment. |
|
|
Oct 22, 2012 |
3969 |
| Oral MS drug performs well: medication similar to one now used against psoriasis. |
Seppa, Nathan |
|
Oct 20, 2012 |
534 |
| XBiotech Announces Progress in Clinical Development of Treatment for Psoriasis. |
|
|
Oct 17, 2012 |
718 |
| Psoriasis nearly doubles diabetes risk. |
|
|
Oct 16, 2012 |
490 |
| Psoriasis: a skin disorder needs govt's attention. |
|
|
Oct 16, 2012 |
715 |
| Psoriasis: a skin disorder needs govt's attention. |
|
|
Oct 16, 2012 |
715 |
| Idera Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2 Trial of IMO-3100 in Patients with Psoriasis. |
|
|
Oct 15, 2012 |
1859 |
| Psoriasis: a skin disorder needs govt's attention. |
|
|
Oct 15, 2012 |
715 |
| Psoriasis: a skin disorder needs govt's attention. |
|
|
Oct 15, 2012 |
715 |
| Research and Markets: Key Findings from Treatment Algorithms: Psoriasis. |
|
|
Oct 10, 2012 |
397 |
| Interim Analysis Supports Continuation of Can-Fite's Phase 2/3 Psoriasis Clinical Study with CF101. |
|
Clinical report |
Oct 9, 2012 |
805 |
| United States : Janssen Announces Worldwide Agreement To Develop And Commercialize JAK Inhibitor For Immunological Diseases. |
|
|
Oct 3, 2012 |
423 |
| Janssen Announces Worldwide Agreement To Develop And Commercialize JAK Inhibitor For Immunological Diseases. |
|
|
Oct 1, 2012 |
828 |
| Diabetes risk twofold higher with severe psoriasis. |
Zoler, Mitchel L. |
|
Oct 1, 2012 |
625 |
| International Study Highlights Need to Support Patients With Psoriasis Suffering Feelings of Isolation, Stigmatisation and Anxiety. |
|
|
Sep 30, 2012 |
663 |
| International Study Highlights Need to Support Patients With Psoriasis Suffering Feelings of Isolation, Stigmatisation and Anxiety. |
|
|
Sep 30, 2012 |
668 |
| Stiefel receives US FDA approval of Sorilux(TM) Foam, 0.005% for topical treatment of plaque psoriasis of the scalp. |
|
|
Sep 28, 2012 |
1027 |
| Research and Markets: Psoriasis (Event Driven). |
|
|
Sep 28, 2012 |
277 |
| Switzerland : Novartis data show AIN457 significantly reduced signs and symptoms in patients with hard-to-treat moderate-to-severe plaque psoriasis. |
|
|
Sep 28, 2012 |
378 |
| Britney Spears 'may be suffering with psoriasis'. |
|
|
Sep 20, 2012 |
138 |
| Research and Markets: Global Psoriasis Drug Pipeline Capsule - 2012 Update. |
|
|
Sep 18, 2012 |
302 |
| The Zacks Analyst Blog Highlights: Celgene, Amgen, Pfizer, Dow Chemical and EI DuPont de Nemours. |
|
|
Sep 10, 2012 |
1528 |
| PhotoMedex's XTRAC Laser for Treating Psoriasis Featured in Two Dermatology Medical Journals. |
|
|
Sep 5, 2012 |
1077 |
| For the Treatment of Psoriasis, Abbott/Eisai's Humira Has Emerged as the Leading Agent with Major-Market Sales of More Than $1.4 Billion in 2011. |
|
|
Aug 6, 2012 |
595 |
| Psoriasis drugs fall short in real-world settings. |
Jancin, Bruce |
Clinical report |
Aug 1, 2012 |
561 |
| Psoriatic arthritis screening deemed inadequate. |
Jancin, Bruce |
|
Aug 1, 2012 |
587 |
| XenoPort Announces Initiation of a Phase 1 Clinical Trial of XP23829, a Novel Fumarate Analog for the Potential Treatment of Relapsing-Remitting Multiple Sclerosis and Psoriasis. |
|
|
Jul 23, 2012 |
918 |
| United States Market for Psoriatic Arthritis Pharmacotherapy. |
|
|
Jul 10, 2012 |
692 |
| Research and Markets: United States Market for Psoriatic Arthritis Pharmacotherapy. |
|
|
Jul 6, 2012 |
481 |
| International Federation of Psoriasis Associations: Psoriasis - A Global Health Challenge Leading Experts Gather in Stockholm for 3rd World Psoriasis & Psoriatic Arthritis Conference. |
|
Conference news |
Jun 27, 2012 |
735 |
| Psoriasis patients at high risk for developing diabetes. |
|
|
Jun 19, 2012 |
453 |
| New Five Year Data for STELARA,u- (Ustekinumab) Show Consistent Efficacy and Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis. |
|
|
Jun 6, 2012 |
1774 |
| RAPID(TM)-PsA study showed that certolizumab pegol improved the signs and symptoms of psoriatic arthritis. |
|
|
Jun 6, 2012 |
3724 |
| New Phase 3 Data Show STELARA,u- (Ustekinumab) Significantly Reduced Signs and Symptoms of Active Psoriatic Arthritis. |
|
|
Jun 5, 2012 |
1281 |
| New Phase 3 Data Show STELARA Significantly Reduced Signs And Symptoms Of Active Psoriatic Arthritis. |
|
|
Jun 5, 2012 |
2842 |
| UCB to showcase broad immunology portfolio at EULAR 2012. |
|
|
Jun 1, 2012 |
4434 |
| Effective formula for psoriasis. |
Murphy, Kathleen |
Abstract |
Jun 1, 2012 |
532 |
| Recognising psoriasis in children. |
Turnbull, Rosemary |
|
Jun 1, 2012 |
1788 |
| Vigorous physical activity may cut psoriasis risk by 30pc. |
|
|
May 22, 2012 |
374 |
| For Moderate to Severe Psoriasis, Surveyed U.S. Dermatologists Would Accept a Substantial Decrease in Efficacy Compared with Enbrel in Order to Have an Oral Therapy with a Lower Rate of Serious Infection and Comparable Safety Profile. |
|
|
May 21, 2012 |
647 |
| National Psoriasis Foundation awards more than $2 million for research. |
|
|
May 15, 2012 |
636 |
| Psoriasis patients 'at increased risk of cardiovascular disease'. |
|
|
May 11, 2012 |
648 |
| Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments. |
|
|
May 10, 2012 |
3359 |
| Idera Pharmaceuticals Announces Efficacy Data for IMO-8400 in Preclinical Models of Lupus and Psoriasis. |
|
|
May 7, 2012 |
1359 |
| Idera Pharmaceuticals Announces Presentation of Preclinical Data of IMO-8400 in Both Lupus and Psoriasis Models. |
|
|
May 1, 2012 |
1240 |
| Research and Markets: Psoriasis - Oral and Novel Biologics to Change Future Market Dynamics. |
|
|
May 1, 2012 |
241 |
| Psoriasis patients have lower pregnancy rates. |
Pfeiffer, Amy |
Medical condition overview |
May 1, 2012 |
474 |
| Psoriasis not an independent cardiac risk factor. |
Brunk, Doug |
|
May 1, 2012 |
578 |
| Abbott Japan and Eisai have Cleared the Condition for Approval of Humira(R), a Fully Human Anti-TNF-Alpha Monoclonal Antibody, for Plaque Psoriasis and Psoriasis Arthropica in Terms of the All-Case Surveillance. |
|
|
Apr 24, 2012 |
347 |
| Treatment Algorithms: Psoriasis - Prescribing trends mirror guidelines. |
|
|
Apr 23, 2012 |
1761 |
| Despite a Slight Increase in the Use of Biologic Agents to Treat Psoriasis in the Past Year, Dermatologists in the EU Are Not Expected to Drastically Change Their Future Prescribing Habits. |
|
|
Apr 18, 2012 |
509 |
| Idera Pharmaceuticals Announces Initiation of Treatment in Phase 2 Clinical Trial of IMO-3100 for Psoriasis. |
|
|
Apr 17, 2012 |
1446 |
| New psoriasis drug reduces vessel inflammation. |
Wachter, Kerri |
|
Apr 15, 2012 |
687 |
| Monoclonal antibody injections clear psoriasis at 12 weeks. |
Moon, Mary Ann |
|
Apr 15, 2012 |
753 |
| SHOW IN AID OF PSORIASIS. |
|
|
Apr 12, 2012 |
147 |
| XenoPort Awarded U.S. Patent Directed to Composition and Formulations of XP23829, a Novel Fumarate Analog for the Potential Treatment of Relapsing-Remitting Multiple Sclerosis and Psoriasis. |
|
|
Apr 4, 2012 |
763 |
| Support group sought for psoriasis patients. |
|
|
Mar 30, 2012 |
361 |
| Research and Markets: Psoriasis - Prescribing Trends Mirror Guidelines. |
|
|
Mar 29, 2012 |
459 |
| Lilly's Anti-IL-17 Monoclonal Antibody, Ixekizumab, Met Primary Endpoint in Phase II Study in Patients With Chronic Plaque Psoriasis. |
|
|
Mar 28, 2012 |
1621 |
| Research and Markets: Psoriasis - Pipeline Review, H1 2012. |
|
|
Mar 19, 2012 |
425 |
| Provectus Announces Top Line Phase 2 Data For PH-10 in Its First Randomized Controlled Psoriasis Study. |
|
Clinical report |
Mar 19, 2012 |
1013 |
| New psoriasis treatment can cut risk of heart attack and stroke. |
|
|
Mar 17, 2012 |
371 |
| VBL Therapeutics Presents Positive Phase 2 Data for VB-201 in Psoriasis and Atherosclerosis at the Late-Breaking Abstract Session of the American Academy of Dermatology 70th Annual Meeting. |
|
|
Mar 16, 2012 |
1279 |
| Obesity elevates risk for psoriatic arthritis. |
Jancin, Bruce |
|
Mar 15, 2012 |
686 |
| Psoriatic arthritis's pathogenesis differs widely from RA's. |
Jancin, Bruce |
|
Mar 15, 2012 |
928 |
| Psoriasis therapy: don't forget the classics. |
Splete, Heidi |
|
Mar 15, 2012 |
252 |
| World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments). |
|
|
Mar 12, 2012 |
3695 |
| LEO Pharma Inc. Debuts Patient Assistance Program for Plaque Psoriasis Patients. |
|
|
Mar 6, 2012 |
1154 |
| Psoriasis guidelines support aggressive approach. |
Wendling, Patrice |
|
Mar 1, 2012 |
1109 |
| Arthritis pattern in psoriasis guides diagnosis. |
Jancin, Bruce |
|
Mar 1, 2012 |
594 |
| TNF inhibitors did not raise risk of zoster in large study. |
Jancin, Bruce |
Clinical report |
Mar 1, 2012 |
686 |
| Creabilis Announces Start of Phase IIb Trial of TrkA Kinase Inhibitor CT327 in Psoriasis. |
|
|
Feb 29, 2012 |
599 |
| Creabilis Announces Start of Phase IIb Trial of TrkA Kinase Inhibitor CT327 in Psoriasis. |
|
|
Feb 29, 2012 |
594 |
| National Psoriasis Foundation Launches "Seal of Recognition" for Psoriasis Products. |
|
|
Feb 28, 2012 |
822 |
| Why stress makes problem skin worse. |
|
|
Feb 21, 2012 |
316 |
| Why stress makes problem skin worse; health focus. |
|
|
Feb 21, 2012 |
316 |
| Early treatment aids quality of life in psoriasis. |
Splete, Heidi |
|
Feb 15, 2012 |
536 |
| Psoriasis: location matters when selecting topical therapy. |
Splete, Heidi |
|
Feb 15, 2012 |
689 |
| FDA Approves Additional Manufacturer of Methoxsalen. |
|
|
Feb 15, 2012 |
879 |
| National Psoriasis Foundation Releases Consensus Guidelines for Treatment of Plaque Psoriasis. |
|
|
Jan 25, 2012 |
503 |
| OUR HEALTH expert. |
|
|
Jan 11, 2012 |
597 |
| Biocon Announces Positive Efficacy Data with its Novel Monoclonal Antibody Itolizumab in a Pivotal Psoriasis Study. |
|
|
Jan 9, 2012 |
567 |
| LEO Pharma A/S In-Licenses Promising Compound From Virobay Inc. for Oral Treatment of Psoriasis. |
|
|
Jan 9, 2012 |
786 |
| Avexxin Receives Series A Second Tranche. |
|
|
Jan 9, 2012 |
385 |
| Switching biologics for psoriasis 'okay'. |
Tucker, Miriam E. |
|
Jan 1, 2012 |
526 |
| Kim Kardashian's psoriasis flares up due to marriage stress. |
|
|
Dec 18, 2011 |
160 |
| International Federation of Psoriasis Associations: Psoriasis - Affecting Not Only the Afflicted. |
|
|
Dec 14, 2011 |
709 |
| Idera Pharmaceuticals Announces FDA Authorization to Proceed with a Phase 2 Clinical Trial of IMO-3100 in Patients with Psoriasis. |
|
|
Dec 1, 2011 |
703 |
| Comorbid vitiligo and psoriasis? Keep looking. |
Jancin, Bruce |
|
Dec 1, 2011 |
545 |
| Safety concerns loom over psoriasis pipeline: biologics and small molecule agents show promise in early phase trials. Larger studies are needed. |
Tucker, Miriam E. |
|
Dec 1, 2011 |
927 |
| Psoriasis tied to comorbidities that up cardiovascular risks. |
Brunk, Doug |
|
Dec 1, 2011 |
527 |
| The Psoriasis Drug Market Will Increase from $3.9 Billion in 2010 to More Than $7.4 Billion in 2020. |
|
|
Nov 17, 2011 |
689 |
| In the First Year after Its Approval for Psoriasis, Nearly One-Half of Surveyed U.S. Dermatologists Expect to Prescribe Pfizer's Tofacitinib to Patients Who Failed One Biologic. |
|
|
Nov 15, 2011 |
543 |
| International Federation of Psoriasis Associations: World Psoriasis Day, October 29, 2011 Let's Talk about Psoriasis - and Take Action. |
|
|
Oct 28, 2011 |
603 |
| Leading Psychologist Encourages Talk and Action Among Those Living With Psoriasis to Mark World Psoriasis Day. |
|
|
Oct 28, 2011 |
718 |
| Psychosocial issues add to psoriasis patients' woes. |
|
|
Oct 28, 2011 |
501 |
| Get Prepared for National Psoriasis Awareness Week 1-7 November, 2011. |
|
|
Oct 27, 2011 |
224 |
| Elorac Steps up Efforts for World Psoriasis Day, Oct. 29. |
|
|
Oct 27, 2011 |
418 |
| PhotoMedex Increases Access to Care for Children in Recognition of World Psoriasis Day, Oct. 29. |
|
|
Oct 24, 2011 |
992 |
| STELARA (ustekinumab)is Effective, Well-Tolerated and Improves Quality of Life in Patients With Moderate to Severe Plaque Psoriasis Inadequately Responsive to methotrexate[1,2]. |
|
Clinical report |
Oct 21, 2011 |
1867 |
| STELARA (ustekinumab)is Effective, Well-Tolerated and Improves Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis Inadequately Responsive to Methotrexate[1,2]. |
|
Clinical report |
Oct 21, 2011 |
1724 |
| Research and Markets: Psoriasis - Pipeline Review, H2 2011. |
|
|
Oct 19, 2011 |
404 |
| XTRAC Excimer Laser Provides Relief for Psoriasis Sufferers' Fall Flare-Ups. |
|
|
Oct 17, 2011 |
1152 |
| Competition for Early-Line Biologic Use among Psoriasis Patients Intensifies as Humira Continues to Gain Ground on Enbrel. |
|
|
Oct 5, 2011 |
502 |
| Skin Animation Highlights New Dermatological Formula That Targets Psoriasis. |
|
|
Sep 23, 2011 |
343 |
| CV risks from biologies for psoriasis remain a concern. |
Moon, Mary Ann |
Clinical report |
Sep 15, 2011 |
536 |
| New Dermatological Formula Targets Psoriasis, Eczema and Other Extreme Skin Conditions. |
|
|
Sep 13, 2011 |
376 |
| Kim Kardashian's 'lifesaver' spray that keeps psoriasis spots at bay. |
|
|
Sep 8, 2011 |
133 |
| Medial tibial stress syndrome induced by methotrexate: a case report / metotreksat kaynakli medial tibial stres sendromu: olgu sunumu. |
Moen, Maarten; Weir, Adam; Rijthoven, Andre Van; Reurink, Guus; Tol, Johannes Leonardus; Backx, Fran |
Report |
Sep 1, 2011 |
2036 |
| New-onset palmoplantar psoriasis during treatment of active Ankylosing spondylitis with TNF-alpha blocking agent adalimumab / TNF-alfa bloke edici ajan adalimumabla yurutulen aktif ankilozan spondilit tedavisi sirasinda meydana gelen yeni baslangicli palmoplantar psoriyazis. |
Akgul, Ozgur; Calis, Mustafa; Ozgocmen, Salih |
Disease/Disorder overview |
Sep 1, 2011 |
1006 |
| Drug Market Info Launches Presentation-Ready Reports to Help Companies Understand Specific Disease Markets and What Patients Need. |
|
|
Aug 11, 2011 |
798 |
| PhotoMedex Covers XTRAC Laser Treatment Co-Pay for Children with Psoriasis. |
|
|
Aug 4, 2011 |
1137 |
| Can-Fite BioPharma Announces the Initiation of Patient Enrolment for the Phase 2/3 Psoriasis Study with its Lead Drug CF101. |
|
|
Aug 1, 2011 |
413 |
| In psoriasis, biologics did not raise zoster risk. |
Jancin, Bruce |
|
Aug 1, 2011 |
317 |
| Homeopathy treats psoriasis effectively. |
|
|
Jul 30, 2011 |
419 |
| Kim Kardashian fears career end after psoriasis diagnosis. |
|
|
Jul 26, 2011 |
152 |
| Kim Kardashian suffering from skin condition psoriasis. |
|
|
Jul 23, 2011 |
127 |
| FDA Advisory Committee Recommends Approval of REMICADE for Treatment of Pediatric Ulcerative Colitis. |
|
|
Jul 21, 2011 |
1977 |
| PhotoMedex's 'Itching to Win' Contest Offers Free Phototherapy Treatments With the XTRAC Laser to Deserving Psoriasis Patients Nationwide. |
|
|
Jul 18, 2011 |
1000 |
| National Psoriasis Foundation Creates Patient Bill of Rights and Responsibilities. |
|
|
Jul 11, 2011 |
573 |
| Although Enbrel Remains the Most Commonly Used Biologic for Psoriasis, Patient Share for Humira Continues to Climb. |
|
|
Jul 5, 2011 |
625 |
| Psoriatic arthritis: treatment update. |
Mease, Philip J. |
|
Jul 1, 2011 |
5153 |
| Current Therapy for Seronegative Arthritides (Spondyloarthritis). |
Dougados, Maxime |
|
Jul 1, 2011 |
2032 |
| National Psoriasis Foundation Awards 12 Psoriasis Research Fellowships. |
|
|
Jun 30, 2011 |
846 |
| Drugs for rheumatoid arthritis, psoriasis may cut diabetes risk. |
|
|
Jun 22, 2011 |
256 |
| Psoriasis Patients Are Saying 'Here Comes The Sun'. |
|
|
Jun 21, 2011 |
634 |
| My skin shame; I fear new love will hate scales. |
|
|
Jun 19, 2011 |
294 |
| Clobex/Vectical combo effective for psoriasis. |
|
|
Jun 15, 2011 |
348 |
| Actinobac Biomed, Inc. Demonstrates In Vivo Efficacy for Psoriasis Treatment. |
|
|
Jun 14, 2011 |
514 |
| XTRAC Laser Provides New Hope for Children with Psoriasis. |
|
|
Jun 8, 2011 |
863 |
| Psoriasis Charity Gets Certification. |
|
|
May 31, 2011 |
653 |
| Common drug for leukemia, psoriasis may fight vascular disease. |
|
|
May 28, 2011 |
225 |
| Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel (etanercept) for Patients with Chronic Inflammatory Conditions. |
|
Clinical report |
May 25, 2011 |
3981 |
| New Four Year STELARA Data Show Consistent Safety Profile Over Time in Patients With Moderate to Severe Plaque Psoriasis. |
|
Clinical report |
May 25, 2011 |
3261 |
| Provectus Pharmaceuticals Completes Patient Accrual in Phase 2C Clinical Trial of PH-10 for Psoriasis. |
|
|
May 24, 2011 |
573 |
| Extremely Obese Children Have Higher Prevalence of Psoriasis, Higher Heart Disease Risk. |
|
Clinical report |
May 18, 2011 |
1141 |
| LEO Pharma Inc. Launches Enhanced Website for Taclonex[R] Plaque Psoriasis Treatments. |
|
|
Apr 28, 2011 |
956 |
| Anacor Pharmaceuticals to Present New Data on AN2728 and GSK '052 at Upcoming Meetings. |
|
|
Apr 18, 2011 |
610 |
| Psoriasis appears to drive up cardiovascular risks. |
Zoler, Mitchel L. |
Clinical report |
Apr 15, 2011 |
933 |
| National Psoriasis Foundation awards $750,000 in research grants. |
|
|
Apr 11, 2011 |
1025 |
| Psoriasis seen as anti-TNF therapy side effect. |
Jancin, Bruce |
|
Apr 1, 2011 |
966 |
| Clinical Trial Offers New Hope for Moderate to Severe Psoriasis Sufferers. |
|
|
Mar 29, 2011 |
836 |
| Anacor Pharmaceuticals Secures $30 Million Loan Facility. |
|
|
Mar 21, 2011 |
1169 |
| Anacor Pharmaceuticals Completes Enrollment in Phase 2b Trial of AN2728 for Psoriasis. |
|
|
Mar 14, 2011 |
606 |
| Psoriasis drug may help in the fight against multiple sclerosis. |
|
|
Mar 9, 2011 |
327 |
| World-Class Professional Golfer Phil Mickelson Launches 'On Course with Phil' for People with Certain Inflammatory Joint and Skin Conditions. |
|
|
Mar 2, 2011 |
1469 |
| Ofuji'nin papuloeritrodermasi: iki olgu sunumu: papuloerythroderma of Ofuji: a report of two cases. |
Sarici, Gulben; Koca, Rafet; Isik, Selda; Sezer, Tuna; Cinar, Saniye; Kandemir, Nilufer Onak |
|
Mar 1, 2011 |
2486 |
| CalciMedica Initiates Phase I Clinical Trial of First CRAC Channel Inhibitor (CCI) for Psoriasis. |
|
|
Feb 17, 2011 |
550 |
| TNF inhibitors for psoriasis linked to 48% cut in MI. |
Jancin, Bruce |
|
Feb 15, 2011 |
577 |
| Biologics may increase cardiovascular risk in psoriasis. |
Boschert, Sherry |
|
Feb 15, 2011 |
957 |
| Psoriasis may double metabolic syndrome risk. |
Moon, Mary Ann |
|
Feb 15, 2011 |
588 |
| For the Treatment of Moderate to Severe Psoriasis, the Highest Proportion of Surveyed Dermatologists and MCOs Indicate That Humira and Enbrel Have the Best Overall Clinical Profile When Compared to Other Currently Available Agents. |
|
|
Feb 7, 2011 |
780 |
| Anacor Pharmaceuticals Announces First Patient Dosed in a Phase 2b Trial of AN2728 for Psoriasis. |
|
|
Feb 4, 2011 |
752 |
| Enbrel (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis. |
|
|
Feb 4, 2011 |
3273 |
| National Psoriasis Foundation Partners with Inspire.com to Improve Online Message Board. |
|
|
Jan 20, 2011 |
553 |
| Reportlinker Adds Pipeline and Commercial Insight: Psoriasis - Established brands challenged by new therapies. |
|
|
Jan 11, 2011 |
716 |
| Avexxin Closes Financing Round. |
|
|
Jan 10, 2011 |
509 |
| Features of metabolic syndrome prevalent in people with psoriasis. |
|
|
Dec 21, 2010 |
288 |
| Provectus Pharmaceuticals Initiates Phase 2c Clinical Trial of PH-10 for Psoriasis. |
|
Clinical report |
Dec 14, 2010 |
697 |
| Topical tar making a comeback in psoriasis treatment. |
Boschert, Sherry |
Report |
Dec 1, 2010 |
725 |
| Skin lesions complicate anti-TNF therapy for IBD. |
Napoli, Denise |
Report |
Dec 1, 2010 |
716 |
| Jon Lovitz Reveals Decade-Long Battle with Psoriasis in National Awareness Campaign Are You Serious?(TM). |
|
|
Dec 1, 2010 |
822 |
| Although Enbrel Will Remain Surveyed Dermatologists' Most-Prescribed First-Line Biologic for Psoriasis, It Will Lose Market Share in This Line to the Il-12/Il-23 Inhibitors. |
|
|
Dec 1, 2010 |
769 |
| International Federation of Psoriasis Associations: Announcing the Winner of the under the Spotlight Award 2010 for Best International Documentary on Psoriasis. |
|
|
Nov 16, 2010 |
538 |
| Trial clarifies methotrexate dosing in psoriasis. |
Jancin, Bruce |
Report |
Nov 15, 2010 |
640 |
| Tonsillectomy may cut strep-triggered psoriasis: the surgery removes an important source of T cells. |
Jancin, Bruce |
Report |
Nov 15, 2010 |
492 |
| Psoriasis.. more than skin deep. |
|
|
Nov 1, 2010 |
434 |
| Etanercept dosing defined for psoriasis, PsA. |
Jancin, Bruce |
Clinical report |
Nov 1, 2010 |
695 |
| Heliotherapy: a South African perspective. |
Moosa, Y.; Esterhuyse, D.J. |
Report |
Nov 1, 2010 |
6736 |
| Nearly Half of Kids With Psoriasis Surveyed Report Being Bullied. |
|
|
Oct 25, 2010 |
665 |
| Four new psoriasis 'hotspots' identified. |
|
|
Oct 19, 2010 |
268 |
| Practicing Clinicians Exchange Forms Partnership With National Psoriasis Foundation. |
|
|
Oct 18, 2010 |
734 |
| Four New Psoriasis 'Hotspots' Identified By U-M Geneticists. |
|
Disease/Disorder overview |
Oct 18, 2010 |
964 |
| Pfizer Inc.'s. |
|
|
Oct 11, 2010 |
244 |
| Oral Tasocitinib Demonstrates Statistically Significant Response by 12 Weeks in Phase 2 Study of People With Moderate to Severe Plaque Psoriasis. |
|
|
Oct 7, 2010 |
1625 |
| Surveyed Dermatologists and Rheumatologists Expect to Increase Their First-Line DMARD Use of Centocor Ortho Biotech's Simponi for the Treatment of Psoriatic Arthritis. |
|
|
Oct 5, 2010 |
623 |
| Psoriasis tied to increased risk of psychiatric disorders in kids. |
Worcester, Sharon |
Clinical report |
Oct 1, 2010 |
530 |
| For the Treatment of Psoriasis, Humira Will Likely Gain First-Line Patient Share Among Biologics at the Expense of Enbrel. |
|
|
Sep 22, 2010 |
801 |
| Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis(TM)' Hosted by Tim Gunn. |
|
|
Sep 22, 2010 |
1825 |
| Largest single collection of psoriasis DNA samples offers hope to sufferers. |
|
|
Sep 2, 2010 |
406 |
| DNA from National Psoriasis Victor Henschel BioBank Released for Study. |
|
|
Sep 1, 2010 |
645 |
| Vitamin D and the skin. |
|
Brief article |
Sep 1, 2010 |
121 |
| General overview of German and Turkish dermatology education: similarities and differences between University of Tubingen Dermatology (UKT) and Gazi University Medical Faculty Department of Dermatology/Almanya ve Turkiye'deki Dermatoloji Egitimine Genel Bakis: Tubingen Universitesi Dermatoloji Klinigi ile Gazi Universitesi Tip Fakultesi Dermatoloji Klinigi Arasinda Benzerlik ve Farklar. |
Onder, Meltem |
Editorial |
Sep 1, 2010 |
2575 |
| Bullous pemphigoid in a patient with psoriasis treated with cyclosporine/ Psoriasisli hastada bulloz pemfigoid gelisimi ve siklosporin ile ortak tedavi. |
Ulusal, Hande Arda; Su, Ozlem; Cebeci, Filiz; Sakiz, Damlanur; Onsun, Nahide |
Clinical report |
Sep 1, 2010 |
998 |
| New Report World Dermatology Market (Drugs, Therapeutic Segments and Disorders) (2010 to 2015) Published By MarketsandMarkets. |
|
|
Aug 31, 2010 |
1131 |
| BEER-SWILLING ladettes who emulate the [...]. |
|
|
Aug 23, 2010 |
251 |
| Women beer drinkers show a higher risk for psoriasis. |
|
|
Aug 20, 2010 |
141 |
| Drinking beer 'can lead to psoriasis in women'. |
|
|
Aug 17, 2010 |
438 |
| Skin condition linked to depression, anxiety and suicidal feelings. |
|
|
Aug 17, 2010 |
227 |
| Abbott Launches New Psoriasisanswers.com Web site. |
|
|
Aug 12, 2010 |
867 |
| The Continued Uptake of Interleukin Inhibitors and TNF-alpha Inhibitors and Increasing Penetration of Biologics Will Drive the Psoriasis Drug Market to Double to $6.8 Billion in 2019. |
|
|
Aug 9, 2010 |
660 |
| STELARA Three-Year Efficacy and Safety Data Presented on Patients with Moderate to Severe Plaque Psoriasis. |
|
Clinical report |
Aug 9, 2010 |
2433 |
| Elorac, Inc. Launches the Avenue to Access[TM] Free Psoriasis Medication Program. |
|
|
Aug 4, 2010 |
768 |
| Topical anti-inflammatory potential of physalin E from Physalis angulata on experimental dermatitis in mice. |
Pinto, N.B.; Morais, T.C.; Carvalho, K.M.B.; Silva, C.R.; Andrade, G.M.; Brito, G.A.C.; Veras, M.L.; |
Report |
Aug 1, 2010 |
2544 |
| New Psoriasis eCommerce Shop Launched by PAPAA. |
|
|
Jul 15, 2010 |
409 |
| New Website Helps Children with Psoriasis Live Better with Their Condition. |
|
Website overview |
Jul 15, 2010 |
521 |
| National Psoriasis Foundation Launches Medical Dermatology Fellowship Program. |
|
|
Jun 30, 2010 |
823 |
| Valeant Pharmaceuticals Resumes Shipment of Oxsoralen-Ultra(R). |
|
|
Jun 23, 2010 |
923 |
| Satisfied With Stelara's Efficacy and Dosing, Nearly Three-Quarters of Surveyed Dermatologists Will Increase Its Use for the Treatment of Psoriasis Over the Next Year. |
|
|
Jun 23, 2010 |
797 |
| Insurance Issues Hinder Treatment for 33 Percent of Psoriasis Patients. |
|
|
Jun 17, 2010 |
723 |
| PhotoMedex Announces Clinical Trial Using the XTRAC Velocity[R] Laser in the Treatment of Severe Generalized Psoriasis. |
|
Clinical report |
Jun 7, 2010 |
550 |
| Can-Fite BioPharma Announces Opening of CF101 Dermatology IND with Phase 2/3 Psoriasis Protocol. |
|
|
Jun 7, 2010 |
640 |
| Ustekinumab aided sexual function in psoriasis. |
McNamara, Damian |
|
Jun 1, 2010 |
561 |
| Psoriasis tied to increased risk for CV events. |
Zoler, Mitchel L. |
|
Jun 1, 2010 |
556 |
| Psoriasis detection using skin color and texture features. |
Abbadi, Nidhal K. Al; Dahir, Nizar Saadi; Dhalimi, Muhsin A. AL-; Restom, Hind |
Report |
Jun 1, 2010 |
2671 |
| Psychoneuroimmunology and multifactorial psychodermatological diseases/Psikonoroimmunoloji ve multifaktoryel psikodermatolojik hastaliklar. |
Altunay, Ilknur Kivanc |
Report |
Jun 1, 2010 |
4166 |
| Journal abstracts: vitamin D and the skin. |
|
Author abstract |
Jun 1, 2010 |
121 |
| Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: case series and literature overview / Tumor nekrosis faktor-alfa anhibitoru kullanimina bayli olarak geliaen psoriazis: olgu serisi ve literaturun gozden gecirilmesi. |
Sarpel, Tunay; BaAaran, Sibel; Akcam, Filiz DoCan; GunaAti, Suhan; Denli, YaAargul |
Report |
Jun 1, 2010 |
2390 |
| STELARA(TM) Significantly Improves Symptoms of Depression, Anxiety and Health-Related Quality of Life in Patients With Moderate to Severe Psoriasis. |
|
|
May 19, 2010 |
1607 |
| VBL Therapeutics Announces Positive Preclinical Data for VB-201 against Psoriasis - First in New Class of Orally Available Anti-Inflammatory Compounds. |
|
Clinical report |
May 7, 2010 |
874 |
| Readers respond to recent topics. |
|
Brief article |
May 1, 2010 |
213 |
| A comparative real time study of stability of cream and ointment formulations of clobetasol propionate in drug stores of Bangladesh. |
Paul, Alok Kumar; Kundu, Sukalyan Kumar; Ahsan, Shamima; Jamal, Farhana; Ahmed, Rasheda; Nahar, Nusr |
Report |
May 1, 2010 |
2969 |
| Ten Scientists Receive National Psoriasis Foundation Research Grants. |
|
|
Apr 27, 2010 |
1035 |
| Guideline on the management of psoriasis in South Africa. |
Raboobee, N.; Aboobaker, J.; Jordaan, H.F.; Sinclair, W.; Smith, J.M.; Todd, G.; Weiss, R.; Whitaker |
|
Apr 1, 2010 |
17329 |
| Research and Markets: The Book on Psoriasis Will Appeal To Physicians with an Interest in Inflammatory Skin Diseases with Systemic Associations. |
|
|
Mar 24, 2010 |
179 |
| Humira Replaces Enbrel as the Therapy Perceived by Dermatologists to be the Most Efficacious for the Treatment of Moderate to Severe Psoriasis. |
|
|
Mar 23, 2010 |
818 |
| Psoriasis, a chronic, immune-mediated disease, is caused by the overproduction of skin cells. |
|
|
Mar 22, 2010 |
253 |
| Effects of Psychologic Intervention on Psoriasis: A Preliminary Report. |
Hartman, David |
Brief article |
Mar 22, 2010 |
167 |
| Trauma linked to development of arthritis in psoriasis. |
Johnson, Kate |
|
Mar 15, 2010 |
588 |
| The prevalance of diabetes in psoriatic patients versus the prevalance of psoriasis in diabetic patients/Psoriasisli hastalarda diyabet gorulme sikligina karsilik diyabetli hastalarda psoriasis gorulme sikligi. |
Onsun, Nahide; Su, Ozlem; Eris, Zahide; Davutoglu, Mihriban; Cebeci, Filiz; Senocak, Mustafa |
Report |
Mar 1, 2010 |
1867 |
| Investigation of serum visfatin levels in patients with psoriasis/Psoriasisli hastalarda serum visfatin duzeylerinin arastirilmasi. |
Bozkurt, Nurhal Mercan; Yildirim, Mehmet; Ceyhan, Ali Murat; Kara, Yusuf; Vural, Huseyin |
Report |
Mar 1, 2010 |
3116 |
| The problems that occurred after discontinuation of efalizumab therapy in psoriasis patients/Efalizumab tedavisinin kesilmesinin psoriasisli hastalarda ortaya cikardigi sorunlar. |
Adisen, Esra; Tezel, Fulya; Gurer, Mehmet Ali |
Clinical report |
Mar 1, 2010 |
4106 |
| An infantile pustular psoriasis case successfully treated with acitretin/Asitretin ile basarili sekilde tedavi edilen infantil pustuler psoriasis olgusu. |
Afsar, Fatma Sule; Ergin, Malik; Diniz, Gulden; Ortac, Ragip |
Case study |
Mar 1, 2010 |
1503 |
| SMC Accepts Janssen-Cilag's Stelara(R) Black Triangle Drug for use in NHS Scotland for the Treatment of Moderate to Severe Plaque Psoriasis; - For Medical Media Only; - Evidence Demonstrates Superior Efficacy and Cost-Effectiveness to Etanercept. |
|
|
Feb 8, 2010 |
1131 |
| Effects do not always stop with the skin. |
|
Disease/Disorder overview |
Feb 1, 2010 |
384 |
| LEO Pharma Officially Launches in the United States. |
|
Company overview |
Jan 19, 2010 |
807 |
| STELARA(TM) (ustekinumab) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis. |
|
Clinical report |
Jan 14, 2010 |
1583 |
| Research and Markets: Psoriasis Report - Detailed Drug Pipeline Analysis and Market Forecasts to 2015. |
|
Report |
Jan 7, 2010 |
960 |
| VBL Therapeutics Initiates Phase 2 Clinical Trial of VB-201 in Patients with Psoriasis. |
|
|
Jan 5, 2010 |
916 |
| InNexus Biotechnology Develops New Psoriasis Product Based on Its Skin Permeating Antibody Technology. |
|
|
Jan 5, 2010 |
624 |
| New psoriasis solution? |
|
|
Jan 1, 2010 |
244 |
| Ustekinumab aids sexual function in psoriasis. |
Jancin, Bruce |
|
Jan 1, 2010 |
318 |
| Psoriasis effects go beyond the skin. |
|
|
Dec 30, 2009 |
442 |
| Positive Phase IIb Topline Clinical Data for Celgene Oral Compound Apremilast (CC-10004) Reported for Patients with Moderate-to-Severe Psoriasis. |
|
Clinical report |
Dec 15, 2009 |
845 |
| Are there any new psoriasis medicines? |
|
|
Dec 6, 2009 |
692 |
| Keratinocyte apoptosis is decreased in psoriatic epidermis/ Psoriatik epidermiste keratinosit apoptozisi azalmistir. |
Tatlican, Semih; Arikok, Ata Turker; Gulbahar, Ozlem; Eren, Cemile; Ulukaradag, Zeliha; Eskioglu, Fa |
Report |
Dec 1, 2009 |
1714 |
| More on skin treatments. |
Fishman, Harvey M. |
|
Dec 1, 2009 |
798 |
| Provectus Announces Preliminary Phase 2 Data For PH-10 in its Psoriasis and Atopic Dermatitis Trials. |
|
|
Dec 1, 2009 |
811 |
| Diagnose and treatment of nail psoriasis/Psoriatik tirnak tani ve tedavisi. |
Kulluk, Pinar; Utas, Serap |
Report |
Dec 1, 2009 |
2869 |
| Alexithymia and anger in patients with psoriasis/Psoriasis hastalarinda aleksitimi ve ofke. |
Gulec, Medine Yazici; Kilic, Arzu; Gul, Ulker; Gulec, Huseyin |
Report |
Dec 1, 2009 |
4218 |
| International Psoriasis Council Hosts Second Educational Symposium to Increase Global Knowledge of Psoriasis. |
|
|
Nov 16, 2009 |
671 |
| Turmeric may help offer treatments for colon cancer, psoriasis, Alzheimer's. |
|
|
Nov 5, 2009 |
217 |
| Homeopathic Clinic at Dubai Healthcare City, Dr Batra's Reaches out to psoriasis patients. |
|
|
Nov 3, 2009 |
550 |
| Psoriasis linked with a host of comorbidities. |
Brunk, Doug |
Report |
Nov 1, 2009 |
871 |
| Recoveries from "auto-immune" disease. |
Gerson, Charlotte |
|
Nov 1, 2009 |
943 |
| Psoriasis Tx deemed 'challenging' in pregnancy. |
Mahoney, Diana |
|
Nov 1, 2009 |
1314 |
| Mind-body connection has role in coping with psoriasis. |
Bankhead, Charles |
|
Nov 1, 2009 |
378 |
| On World Psoriasis Day the International Psoriasis Council Hosts Latin American Dermatologists for Educational Symposium to Elevate Global Knowledge of Psoriasis. |
|
|
Oct 29, 2009 |
534 |
| International Federation of Psoriasis Associations, IFPA: Psoriasis is a real disability that deserves attention! |
|
|
Oct 28, 2009 |
1509 |
